• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cyclin-A2 (CCNA2)

ACP01198

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01198 Target NameCCNA2
Target Synonyms(Cyclin-A)(Cyclin A)FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-432aa
Mol Weight54.6 kDaProtein LengthFull length
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP20248
Background Information
  • Uniprot Id

    P20248

  • Target Species

    Human

  • Target Name

    CCNA2

  • Target Full Name

    Cyclin-A2

  • Target Function

    Cyclin which controls both the G1/S and the G2/M transition phases of the cell cycle. Functions through the formation of specific serine/threonine protein kinase holoenzyme complexes with the cyclin-dependent protein kinases CDK1 or CDK2. The cyclin subunit confers the substrate specificity of these complexes and differentially interacts with and activates CDK1 and CDK2 throughout the cell cycle.

  • Target Subcellular Location

    Nucleus. Cytoplasm.

  • Target Protein Families

    Cyclin family, Cyclin AB subfamily

  • Target Research Area

    Cancer

  • Target Synonyms

    CCN1; CCNA; Ccna2; CCNA2_HUMAN; Cyclin A2; Cyclin-A; Cyclin-A2

  • Target Background

    The protein encoded by this gene belongs to the highly conserved cyclin family, whose members function as regulators of the cell cycle. This protein binds and activates cyclin-dependent kinase 2 and thus promotes transition through G1/S and G2/M.

Inquire Recombinant Human Cyclin-A2 (CCNA2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification